PRCT

PROCEPT BioRobotics CorporationNASDAQHealthcare

$25.12-0.95%ClosedMarket Cap: $1.42B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-02	Truist Securities	—	Buy	—
2026-02-26	Wells Fargo	—	Overweight	—
2026-02-26	Leerink Partners	—	Outperform	—
2026-02-26	Piper Sandler	—	Overweight	—
2026-02-26	B of A Securities	—	Underperform	—
2026-02-26	Oppenheimer	—	Perform	—
2026-02-26	TD Cowen	—	Buy	—
2025-12-18	Truist Securities	—	Buy	—
2025-12-08	B of A Securities	—	Neutral	—
2025-12-02	Morgan Stanley	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.92	$493.1M	9
Sun Dec 31	$-0.59	$583.4M	5
Mon Dec 31	$-0.33	$661.4M	1
Tue Dec 31	$0.41	$737.2M	1

PRCT | PROCEPT BioRobotics Corporation Analyst Ratings & Price Target - InvestLog